Thromboprophylaxis with Low-Molecular- Weight Heparin: Economic Considerations

Publisher： Karger

E-ISSN： 1424-8840|30|2|141-145

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.30, Iss.2, 2004-11, pp. : 141-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of an Optimal Dose of Low-Molecular-Weight Heparin for Thromboprophylaxis in Pregnant Women at Risk of Thrombosis Using Coagulation Activation Markers

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 2, 2001-10 ,pp. : 90-98

Karger

Access to resources Recommend Favorite

Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 1, 2001-06 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

The Economic Impact of Treating Deep Vein Thrombosis with Low-Molecular-Weight Heparin: Outcome of Therapy and Health Economy Aspects

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 8-16

Karger

Access to resources Recommend Favorite

Effect of Low-Molecular-Weight Heparin on Potassium Homeostasis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2002-10 ,pp. : 107-110

Karger

Access to resources Recommend Favorite

Effect of Low Molecular Weight Fucoidan and Low Molecular Weight Heparin in a Rabbit Model of Arterial Thrombosis

By  

Journal of Vascular Research, Vol. 45, Iss. 6, 2008-05 ,pp. : 529-537

Karger

Access to resources Recommend Favorite